Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:54 AM
Ignite Modification Date:
2025-12-25 @ 2:54 AM
NCT ID:
NCT02523833
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of chronic hypersensitivity pneumonitis confirmed by:
* patients with known exposure to antigen, tomographic criteria and absence of other diagnoses;
* confirmation with histology obtained by transthoracic biopsy, surgical biopsy or bronchoalveolar lavage with lymphocytosis above 30%;
* Age between 18 to 75 years;
* Clinically stable (no exacerbations or hospitalizations related to the underlying disease) for at least 6 weeks;
* Compliance with signing an informed consent for participation in the project.
Exclusion Criteria:
* Patients with FEV1 and / or DLCO \<30% predicted;
* Patients using supplemental oxygen;
* Previous diagnosis of asthma or COPD;
* Pregnant women;
* Musculoskeletal disorders that limit exercise;
* Another medical condition that might interfere with the execution of tests;
* Current or past smoking history with tobacco intake greater than 30 pack-years;
* Severe heart disease functional class New York Heart Association (NYHA) III-IV) and / or decompensated hear failure.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT02523833
Study Brief:
Protocol Section:
NCT02523833